Literature DB >> 9088276

The European Randomized Study of Screening for Prostate Cancer (ERSPC).

F H Schröder1, C H Bangma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088276     DOI: 10.1111/j.1464-410x.1997.tb00804.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


× No keyword cloud information.
  8 in total

1.  Towards a philosophy of public health.

Authors:  D L Weed
Journal:  J Epidemiol Community Health       Date:  1999-02       Impact factor: 3.710

2.  Screening for prostate cancer. Key studies have only just started.

Authors:  D Hrouda; J H Davies; R S Kirby
Journal:  BMJ       Date:  1998-06-20

3.  Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.

Authors:  Anita V Mitra; Elizabeth K Bancroft; Yolanda Barbachano; Elizabeth C Page; C S Foster; C Jameson; G Mitchell; G J Lindeman; A Stapleton; G Suthers; D G Evans; D Cruger; I Blanco; C Mercer; J Kirk; L Maehle; S Hodgson; L Walker; L Izatt; F Douglas; K Tucker; H Dorkins; V Clowes; A Male; A Donaldson; C Brewer; R Doherty; B Bulman; P J Osther; M Salinas; D Eccles; K Axcrona; I Jobson; B Newcombe; C Cybulski; W S Rubinstein; S Buys; S Townshend; E Friedman; S Domchek; T Ramon Y Cajal; A Spigelman; S H Teo; N Nicolai; N Aaronson; A Ardern-Jones; C Bangma; D Dearnaley; J Eyfjord; A Falconer; H Grönberg; F Hamdy; O Johannsson; V Khoo; Z Kote-Jarai; H Lilja; J Lubinski; J Melia; C Moynihan; S Peock; G Rennert; F Schröder; P Sibley; M Suri; P Wilson; Y J Bignon; S Strom; M Tischkowitz; A Liljegren; D Ilencikova; A Abele; K Kyriacou; C van Asperen; L Kiemeney; D F Easton; Rosalind A Eeles
Journal:  BJU Int       Date:  2010-09-14       Impact factor: 5.588

4.  Cost-effectiveness analysis of prostate cancer screening.

Authors:  C Hamashima; K Yoshida
Journal:  Environ Health Prev Med       Date:  2000-10       Impact factor: 3.674

5.  What we have learned from randomized trials of prostate cancer screening.

Authors:  Richard M Hoffman; Anthony Y Smith
Journal:  Asian J Androl       Date:  2011-04-11       Impact factor: 3.285

6.  Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.

Authors:  Veda N Giri; Brian Egleston; Karen Ruth; Robert G Uzzo; David Y T Chen; Mark Buyyounouski; Susan Raysor; Stanley Hooker; Jada Benn Torres; Teniel Ramike; Kathleen Mastalski; Taylor Y Kim; Rick Kittles
Journal:  Cancer Prev Res (Phila)       Date:  2009-02-24

7.  Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.

Authors:  Frances J Drummond; Anne-Elie Carsin; Linda Sharp; Harry Comber
Journal:  BMC Fam Pract       Date:  2009-01-12       Impact factor: 2.497

8.  A personalised approach to prostate cancer screening based on genotyping of risk founder alleles.

Authors:  C Cybulski; D Wokołorczyk; W Kluźniak; A Kashyap; A Gołąb; M Słojewski; A Sikorski; M Puszyński; M Soczawa; T Borkowski; A Borkowski; A Antczak; J Przybyła; M Sosnowski; B Małkiewicz; R Zdrojowy; P Domagała; K Piotrowski; J Menkiszak; K Krzystolik; J Gronwald; A Jakubowska; B Górski; T Dębniak; B Masojć; T Huzarski; K R Muir; A Lophatananon; J Lubiński; S A Narod
Journal:  Br J Cancer       Date:  2013-05-30       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.